A new chapter is beginning for iPSCs: Qihan Biotech, a leading innovator in cell engineering, has reported the first clinical use of an induced pluripotent stem cell (iPSC)-derived CAR natural killer (NK) therapy in an autoimmune disease. The product, known as QN-139b, was administered to a patient with refractory systemic sclerosis (SSc), marking the first time an iPSC-derived CAR immune therapy has been used beyond oncology. [Read more…]
Kexing Biopharm’s Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Registered with FDA DMF
SHENZHEN, China, Sept. 16, 2025 — Kexing Biopharm announced that its investigational Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes has successfully completed a Type II Drug Master File (DMF) registration with the U.S. FDA.
Exosomes, as a next-generation bioactive carrier, boast unique advantages such as low immunogenicity, strong tissue penetration, and potential for targeted modification, offering immense promise for medical applications. However, the technical barriers and research challenges in Exosome development place them at the forefront of complexity among bioactive material fields. [Read more…]
HeartBeat.bio and Boehringer Ingelheim Use Human iPSC-Based Cardioids to Model Inherited Cardiomyopathies
HeartBeat.bio Joins Forces with Boehringer Ingelheim to Advance Gene Therapies for Inherited Heart Muscle Disorders
Vienna, Austria – September 23, 2025 – HeartBeat.bio has entered into a research collaboration with Boehringer Ingelheim to develop gene therapy-based treatments for genetic cardiomyopathies. The partnership combines Boehringer Ingelheim’s expertise in gene therapy drug development with HeartBeat.bio’s proprietary Cardioid Drug Discovery Platform, aiming to advance innovative therapies for inherited heart muscle diseases. [Read more…]
The Pros and Cons of Stem Cell Research in 2026
Interested to understand the importance of stem cell research and recent advancements within this field of study? Today, there are approximately 250 companies worldwide that are developing stem cell products for therapeutic use in humans to address a diverse range of chronic and acute conditions. There are also around astounding 500,000+ scientific publications about stem cells that have been published today in peer-reviewed journals.
In this article, we’ll explore the pros and cons of stem cell research. Let’s dive in.
In this article:
Exploring Advanced Therapies in Diabetes Treatment: A Glimpse into the Future
Diabetes is a chronic condition affecting millions globally, characterized by high blood sugar levels due to the body’s inability to produce or effectively use insulin. Traditional management strategies, including lifestyle modifications and medications, have been vital in controlling diabetes, but they often fall short of addressing the disease’s complexities and long-term complications. In recent years, advanced therapies have emerged, offering new hope for patients.
These therapies encompass innovations such as regenerative medicine, advanced insulin delivery systems, and gene editing technologies, each bringing us closer to more effective and personalized treatments. [Read more…]
- « Previous Page
- 1
- …
- 26
- 27
- 28
- 29
- 30
- …
- 202
- Next Page »




